Ximing Tang

7.3k total citations · 1 hit paper
70 papers, 3.8k citations indexed

About

Ximing Tang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ximing Tang has authored 70 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 29 papers in Molecular Biology. Recurrent topics in Ximing Tang's work include Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Ximing Tang is often cited by papers focused on Lung Cancer Treatments and Mutations (28 papers), Lung Cancer Research Studies (10 papers) and Lung Cancer Diagnosis and Treatment (8 papers). Ximing Tang collaborates with scholars based in United States, China and United Kingdom. Ximing Tang's co-authors include Ignacio I. Wistuba, Waun Ki Hong, B. Nebiyou Bekele, Natalie Ozburn, Diane D. Liu, Marileila Varella‐Garcia, César A. Moran, Carmen Behrens, John D. Minna and Roy S. Herbst and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Ximing Tang

70 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

2007 500 citations Erminia Massarelli, Marileila Varella‐Garcia et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ximing Tang United States	32	1.9k	1.7k	1.6k	1.0k	288	70	3.8k
Noriko Yanagitani Japan	37	1.9k 1.0×	1.9k 1.1×	2.0k 1.2×	833 0.8×	268 0.9×	171	4.3k
Wing‐Kai Chan Taiwan	22	1.4k 0.7×	1.4k 0.8×	1.2k 0.7×	828 0.8×	284 1.0×	57	3.2k
Paola Ulivi Italy	34	1.5k 0.8×	1.7k 1.0×	1.3k 0.8×	1.4k 1.3×	202 0.7×	182	3.7k
Edward Gabrielson United States	31	1.6k 0.8×	1.0k 0.6×	965 0.6×	1.0k 1.0×	371 1.3×	59	3.4k
Alastair Greystoke United Kingdom	28	1.3k 0.7×	2.3k 1.4×	1.3k 0.8×	1.4k 1.3×	274 1.0×	144	3.8k
Kenichi Suda Japan	35	1.7k 0.9×	2.5k 1.5×	2.8k 1.7×	890 0.9×	189 0.7×	130	4.3k
José Manuel Pérez-García Spain	26	1.5k 0.8×	2.0k 1.2×	962 0.6×	891 0.9×	220 0.8×	110	3.5k
David Chen United States	25	1.4k 0.7×	1.4k 0.8×	1.5k 0.9×	877 0.8×	310 1.1×	75	3.6k
Ken A. Olaussen France	29	1.8k 1.0×	1.7k 1.0×	1.5k 0.9×	835 0.8×	108 0.4×	55	3.7k
Tarek A. Bismar Canada	37	2.4k 1.2×	1.1k 0.7×	2.6k 1.6×	1.3k 1.3×	225 0.8×	129	4.8k

Countries citing papers authored by Ximing Tang

Since Specialization

Citations

This map shows the geographic impact of Ximing Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ximing Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ximing Tang more than expected).

Fields of papers citing papers by Ximing Tang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ximing Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ximing Tang. The network helps show where Ximing Tang may publish in the future.

Co-authorship network of co-authors of Ximing Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Ximing Tang. A scholar is included among the top collaborators of Ximing Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ximing Tang. Ximing Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Ximing, et al.. (2025). Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE. Frontiers in Immunology. 16. 1449693–1449693. 1 indexed citations

Patel, Bhakti, Yifan Zhou, Feiyang Ma, et al.. (2024). STAT3 protects hematopoietic stem cells by preventing activation of a deleterious autocrine type-I interferon response. Leukemia. 38(5). 1143–1155. 2 indexed citations

Meric‐Bernstam, Funda, Erkan Yuca, Kurt W. Evans, et al.. (2024). Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models. Clinical Cancer Research. 31(3). 573–587. 7 indexed citations

Tang, Ximing, et al.. (2022). A photoelectrochemical immunosensing platform for ultrasensitive detection of alpha-fetoprotein based on a signal amplification strategy. Bioelectrochemistry. 150. 108351–108351. 12 indexed citations

Xie, Yang, Wei Lü, Shidan Wang, et al.. (2018). Validation of the 12-gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer. Clinical Cancer Research. 25(1). 150–157. 13 indexed citations

Shien, Kazuhiko, Vassiliki A. Papadimitrakopoulou, Carmen Behrens, et al.. (2017). JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non–Small Cell Lung Cancer. Molecular Cancer Therapeutics. 16(10). 2234–2245. 84 indexed citations

Cardnell, Robert J., Carmen Behrens, Lixia Diao, et al.. (2015). An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2. Clinical Cancer Research. 21(15). 3480–3491. 37 indexed citations

Nilsson, Monique B., Uma Giri, Jayanthi Gudikote, et al.. (2015). KDR Amplification Is Associated with VEGF-Induced Activation of the mTOR and Invasion Pathways but does not Predict Clinical Benefit to the VEGFR TKI Vandetanib. Clinical Cancer Research. 22(8). 1940–1950. 10 indexed citations

Cumberbatch, Marie, Ximing Tang, Garry Beran, et al.. (2013). Identification of a Subset of Human Non–Small Cell Lung Cancer Patients with High PI3Kβ and Low PTEN Expression, More Prevalent in Squamous Cell Carcinoma. Clinical Cancer Research. 20(3). 595–603. 22 indexed citations

10.

Behrens, Carmen, Luisa M. Solis, Heather Lin, et al.. (2013). EZH2 Protein Expression Associates with the Early Pathogenesis, Tumor Progression, and Prognosis of Non–Small Cell Lung Carcinoma. Clinical Cancer Research. 19(23). 6556–6565. 123 indexed citations

11.

Tsao, Anne S., Suyu Liu, J. Jack Lee, et al.. (2013). Clinical and Biomarker Outcomes of the Phase II Vandetanib Study from the BATTLE Trial. Journal of Thoracic Oncology. 8(5). 658–661. 19 indexed citations

12.

Lewis, Carol M., Bonnie S. Glisson, Lei Feng, et al.. (2012). A Phase II Study of Gefitinib for Aggressive Cutaneous Squamous Cell Carcinoma of the Head and Neck. Clinical Cancer Research. 18(5). 1435–1446. 131 indexed citations

13.

Tang, Ximing, Humam Kadara, Carmen Behrens, et al.. (2011). Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: Implications in Lung Cancer Pathogenesis and Prognosis. Clinical Cancer Research. 17(8). 2434–2443. 59 indexed citations

14.

Yang, Fei, Ximing Tang, Erick Riquelme, et al.. (2011). Increased VEGFR-2 Gene Copy Is Associated with Chemoresistance and Shorter Survival in Patients with Non–Small-Cell Lung Carcinoma Who Receive Adjuvant Chemotherapy. Cancer Research. 71(16). 5512–5521. 51 indexed citations

15.

Solis, Luisa M., Carmen Behrens, Maria Gabriela Raso, et al.. (2011). Histologic patterns and molecular characteristics of lung adenocarcinoma associated with clinical outcome. Cancer. 118(11). 2889–2899. 85 indexed citations

16.

Kim, Edward S., Waun Ki Hong, J. Jack Lee, et al.. (2010). Biological Activity of Celecoxib in the Bronchial Epithelium of Current and Former Smokers. Cancer Prevention Research. 3(2). 148–159. 39 indexed citations

17.

Raso, Maria Gabriela, Carmen Behrens, Matthew H. Herynk, et al.. (2009). Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation. Clinical Cancer Research. 15(17). 5359–5368. 134 indexed citations

18.

Soh, Junichi, Naoki Okumura, William W. Lockwood, et al.. (2009). Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells. PLoS ONE. 4(10). e7464–e7464. 179 indexed citations

19.

Tang, Ximing, Marileila Varella‐Garcia, Ana C. Xavier, et al.. (2008). Epidermal Growth Factor Receptor Abnormalities in the Pathogenesis and Progression of Lung Adenocarcinomas. Cancer Prevention Research. 1(3). 192–200. 71 indexed citations

20.

Lee, Janet I., Jean‐Charles Soria, Khaled A. Hassan, et al.. (2001). Loss of Fhit expression is a predictor of poor outcome in tongue cancer.. PubMed. 61(3). 837–41. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact